Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04619732
Other study ID # REMO-HYMAP 2020
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 1, 2021
Est. completion date April 30, 2023

Study information

Verified date May 2022
Source Accunea Ltd.
Contact Robert M Learney, MBBS PhD
Phone 02088741839
Email robertlearney@accunea.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A significant number of deceased donor kidneys donated for transplantation are not used and are thrown away due to lack of ways of checking their condition and function before the operation. This significantly reduces the number of potentially life saving transplants. The researchers wish to run a small pilot study to see if it is possible to improve the way transplant kidneys are assessed before transplantation by measuring how well they filter the blood, and how good their metabolism is. The researchers believe this new method will help transplant surgeons make better decisions about which kidneys to use. This pilot study will look at 10 kidneys obtained from older deceased donors. These kidneys are most at risk of being thrown away because of the condition of the donor they came from. At the hospital, these kidneys are usually put onto a machine which pumps cold preservation solution through them for a couple of hours. This time lets the transplant surgeons see how well or poorly the kidney responds to the flowing fluid. In this study the research team will do exactly the same, but also insert a small probe less than a millimetre in diameter into the kidney and the vein (draining blood pipe) and urine output to monitor a number of chemicals made by the kidney. The researchers believe that the changing levels of these chemicals will give the surgeons much more information than they have now. This probe is removed when the kidney is transplanted. Combining these levels with news of how well the patients recover after surgery will allow the research team to design a much larger study to get the right level of information to change the way surgeons choose kidneys and help more transplants happen in the future.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date April 30, 2023
Est. primary completion date April 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - All organs to be used in the study must be intended for transplantation and not already rejected/discarded. - All organs must be sourced from deceased donors through NHSBT in the normal course of clinical activity. - Kidneys must come from marginal or 'imperfect' donors according to current clinical criteria. This typically indicates an age of 60 and over, or 50 and over with one or more premorbid conditions, including renal impairment, cerebrovascular disease, and hypertension. Exclusion Criteria: - Organs from living donors are excluded. - Organs from young healthy donors are excluded. - Organs will be excluded if on the assessment of the clinical team they are not suitable for hypothermic machine perfusion. This indicates organs that have arrived with visible defects, or fall well outside the team's standard criteria for clinical acceptability (excessive time in transit, excessive warm ischaemia time, excessive cold ischaemia time, very poor pre-morbid donor condition).

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Monitoring biochemical concentrations during cold machine perfusion
Three microdialysis probes will be introduced into the kidney tissues, the vein and ureter in order to measure creatinine, glucose and lactate while the organ is undergoing cold perfusion prior to transplantation.

Locations

Country Name City State
United Kingdom Hammersmith Hospital London

Sponsors (2)

Lead Sponsor Collaborator
Accunea Ltd. Imperial College Healthcare NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Post-operative recovery of kidney function Magnitude of change in patient baseline serum creatinine concentration pre- and post-operatively at 30 days (in umol/L) 30 days post-operatively
Secondary Reintervention rate Any need to return the patient to theatre or perform additional procedures following the transplant 30 days post-operatively
Secondary Primary non-function Number of participants with no change in serum creatinine concentration from baseline despite transplantation 30 days post-operatively
Secondary Delayed graft function Number of days with inadequate graft function following surgery (low urine output, static serum creatinine concentration) 30 days post-operatively
Secondary Acute rejection Number of patients experiencing immunological rejection of the organ 30 days post-operatively
Secondary Post-operative complications Rates of the most common complications including arterial, venous, or parenchymal thrombosis, ureteric leak or stenosis 30 days post-operatively
See also
  Status Clinical Trial Phase
Withdrawn NCT05811468 - Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients
Active, not recruiting NCT04166149 - Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA
Completed NCT03723668 - Kidney Transplant Outcome and Organ Acceptance Practice Pattern: A Nationwide Analyses in the US and France
Recruiting NCT03737604 - TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant Phase 4
Completed NCT03765203 - Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients N/A
Completed NCT05809440 - Effectiveness of 20m-MB in KTR Symptom Control N/A
Enrolling by invitation NCT04491227 - Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
Not yet recruiting NCT06396702 - EASE-SOT Pilot Study N/A
Recruiting NCT03310905 - Abdominal Wall Transplant N/A
Recruiting NCT05613010 - Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant N/A
Recruiting NCT06263257 - The Effect of Mandala Therapy on Anxiety and Comfort in Kidney Transplant Recipients N/A
Completed NCT04715412 - Clinical Pharmacy Guided Patient Counselling and Adherence Support on Renal Transplant Recipients N/A
Active, not recruiting NCT05449496 - Dietary Intervention to Improve Kidney Transplant Outcomes N/A
Not yet recruiting NCT06089473 - Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates N/A
Withdrawn NCT04473924 - Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk Phase 2
Completed NCT03760263 - Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus Phase 4
Active, not recruiting NCT03380962 - Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant Phase 1/Phase 2
Active, not recruiting NCT03436368 - Continuous Spinal Anesthesia in Renal Transplantation N/A
Not yet recruiting NCT03322709 - Minimally Invasive Kidney Transplantation N/A
Recruiting NCT03778944 - Enhancing Renal Graft Function During Donor Anesthesia N/A